Skip to main content

Table 5 Adverse events possibly or probably related to the study drug

From: Comparison of ceftriaxone plus macrolide and ampicillin/sulbactam plus macrolide in treatment for patients with community-acquired pneumonia without risk factors for aspiration: an open-label, quasi-randomized, controlled trial

 

CTRX (n = 124)

ABPC/SBT (n = 139)

p-value

Diarrhea

12

7

0.23

Rash

5

7

0.55

Elevated AST or ALT

4

4

1.00

Leukopenia

1

1

1.00

Nausea

1

1

1.00

Fever

1

0

0.48

Elevated creatine kinase

1

0

0.48

Total

25 (22 patients)

20 (19 patients)

 
  1. CTRX Ceftriaxone, ABPC/SBT Ampicillin/sulbactam, AST Aspartate aminotransferase, ALT Alanine aminotransferase